Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia ; volume:13 ; number:6 ; day:30 ; month:6 ; year:2022 ; pages:1-13 ; date:6.2022
Cell death & disease ; 13, Heft 6 (30.6.2022), 1-13, 6.2022
- Urheber
-
Houshmand, Mohammad
Vitale, Nicoletta
Orso, Francesca
Cignetti, Alessandro
Molineris, Ivan
Gaidano, Valentina
Sainas, Stefano
Giorgis, Marta
Boschi, Donatella
Fava, Carmen
Passoni, Alice
Gai, Marta
Geuna, Massimo
Sora, Federica
Iurlo, Alessandra
Abruzzese, Elisabetta
Breccia, Massimo
Mulas, Olga
Caocci, Giovanni
Castagnetti, Fausto
Taverna, Daniela
Oliviero, Salvatore
Pane, Fabrizio
Lolli, Marco Lucio
Circosta, Paola
Saglio, Giuseppe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-022-05028-9
- URN
-
urn:nbn:de:101:1-2022082110191880679404
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Houshmand, Mohammad
- Vitale, Nicoletta
- Orso, Francesca
- Cignetti, Alessandro
- Molineris, Ivan
- Gaidano, Valentina
- Sainas, Stefano
- Giorgis, Marta
- Boschi, Donatella
- Fava, Carmen
- Passoni, Alice
- Gai, Marta
- Geuna, Massimo
- Sora, Federica
- Iurlo, Alessandra
- Abruzzese, Elisabetta
- Breccia, Massimo
- Mulas, Olga
- Caocci, Giovanni
- Castagnetti, Fausto
- Taverna, Daniela
- Oliviero, Salvatore
- Pane, Fabrizio
- Lolli, Marco Lucio
- Circosta, Paola
- Saglio, Giuseppe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Elucidating the role of isocitrate dehydrogenase 3 in acute myeloid leukemia
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
Characterization of the ubiquitin ligase FBXL6 as a novel vulnerability in acute myeloid leukemia
Lysosomal activation and mTOR inhibition synergize to kill myeloid leukemia cells
New Therapeutic Approaches for Cell Growth Inhibition of Acute Myeloid & Lymphoblastic Leukemia
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Elucidating the role of isocitrate dehydrogenase 3 in acute myeloid leukemia
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
Characterization of the ubiquitin ligase FBXL6 as a novel vulnerability in acute myeloid leukemia
Lysosomal activation and mTOR inhibition synergize to kill myeloid leukemia cells
New Therapeutic Approaches for Cell Growth Inhibition of Acute Myeloid & Lymphoblastic Leukemia
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Functional characterisation of mutant isocitrate dehydrogenase in acute myeloid leukemia
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Elucidating the role of isocitrate dehydrogenase 3 in acute myeloid leukemia
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
Characterization of the ubiquitin ligase FBXL6 as a novel vulnerability in acute myeloid leukemia
Lysosomal activation and mTOR inhibition synergize to kill myeloid leukemia cells